Amgen, Inc. (AMGN)

313.85 -7.38 (-2.30%) USD  |  NASDAQ  |  Dec 09, 16:00
314.25 +0.40 (+0.13%) After-Hours: 20:00
More

Amgen Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for AMGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Biogen, Inc. Upgrade
Gilead Sciences, Inc. Upgrade
Johnson & Johnson Upgrade
Eli Lilly & Co. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade